Breast Cancer (Proteomics)
Fas Ligand Is Active in Breast Cancer
Published in Women's Health Weekly, November 29th, 1999
The Fas ligand (FasL) is a membrane-bound protein that sends an apoptotic signal by binding to its receptor Fas. G. Mor, of the Yale University School of Medicine, and associates revealed that this protein is functionally alive in breast cancer and that it is regulated by estrogen, in a study titled, "Immune Cell-Tumor Cell: A Fas/Fas Ligand Lethal Interaction."
Their study was presented at the 6th International Congress on Hormones and Cancer, held September 5-9, 1999, in Jerusalem, Israel.
Mor et al. cultured the human breast cancer MCF-7 cell line that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Cervical Cancer (Screening)
Ineffective Device Used To Take Cervical Smears - Cervical Cancer (Screening)
ASCUS Cytology Is Significant in HIV Positive Women - Cervical Cancer (Radiotherapy)
Blood Transfusion Helps Low Presenting Hemoglobin Levels during Radiotherapy - Depression (Pathology)
Depression Alters Immune System by Decreasing Physical Activity - Eating Disorders
Nearly One Out of 10 Female Soldiers Suffer from Eating Disorders - Gynecological Cancer (Surgery)
Epoetin alpha Is Safe and Effective for Autologous Blood Donation - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
